Alfuzosin Hydrochloride
- Product NDC
- 31722-302
- 11-digit product format
- 317220302
- Labeler code
- 31722
- Product ID
- 31722-302_3fb33b8f-9ec4-4a4b-a520-de154673cfb0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alfuzosin Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Camber Pharmaceuticals
- Application
- ANDA090284
- Marketing category
- ANDA
- Marketing start
- 2012-01-18
- Marketing end
- 0000-00-00
- Substance
- ALFUZOSIN HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 31722-302-01 | 2025-02-18 | C162847 | 48780-1 | 97449f38-c20f-f6ea-e053-dbdaa90aa703 | 8704702e-0889-4a47-9a92-588a8d72d503 |
| 31722-302-05 | 2025-02-18 | C162847 | 48780-1 | 97449f38-c20f-f6ea-e053-dbdaa90aa703 | 8704702e-0889-4a47-9a92-588a8d72d503 |
| 31722-302-30 | 2025-02-18 | C162847 | 48780-1 | 97449f38-c20f-f6ea-e053-dbdaa90aa703 | 8704702e-0889-4a47-9a92-588a8d72d503 |
| 31722-302-01 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c20f-f6ea-e053-dbdaa90aa703 | 8704702e-0889-4a47-9a92-588a8d72d503 |
| 31722-302-05 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c20f-f6ea-e053-dbdaa90aa703 | 8704702e-0889-4a47-9a92-588a8d72d503 |
| 31722-302-30 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c20f-f6ea-e053-dbdaa90aa703 | 8704702e-0889-4a47-9a92-588a8d72d503 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 31722-302-01 | EA - Each | 31722-302 | 69432345-1e91-42ac-addb-bdc57c2ca7da | 1 | 2012-07-24 |
| 31722-302-05 | EA - Each | 31722-302 | 9dedc081-ae88-4e23-8f84-7b9cec4e34f0 | 1 | 2012-07-24 |